For example, lncRNA SNHG16 in breast cancer-derived EVs expands the population of CD73 + γδ T cells through the TGF-β1/Smad5 pathway, thereby boosting the production of pro-tumor metabolite and adenosine to promote tumor growth [136]. This evidence concerns the gene TGFB1 and breast carcinoma.